Thirumalai Chemicals Q1 FY27: Revenue, PAT range, target

What investors are watching ahead of Q1 FY27

Thirumalai Chemicals’ Q1 FY27 results are coming into focus as the July-August 2026 earnings season approaches. The stock was cited trading at Rs.175, alongside a market capitalisation of Rs.2,178 crore. The price-to-earnings multiple was described as “not meaningful”, reflecting losses in recent periods. The preview in the provided context is framed as a range-based estimate rather than a single point forecast. It also places the quarter in the broader context of how investors position ahead of scheduled results windows. Separately, the company disclosed a routine trading window closure that typically precedes quarterly results.

The estimate framework cited in the preview

The preview states it is built on a “trailing-growth framework” applied to the company’s Q1 FY26 base. That base was explicitly stated as revenue of Rs.452 crore and net profit of Rs.-60 crore for Q1 FY26. The most recent year-on-year growth signal referenced was from Q4 FY26. The article also notes that Q4 FY26 revenue was Rs.433 crore and net profit was Rs.-28 crore. These numbers are used as the recent anchor for building expectations into Q1 FY27. The approach indicates the estimate range is derived from trailing information rather than management guidance in the text provided. The output is expressed as a revenue range and a PAT range for Q1 FY27.

Q1 FY27 revenue range: Rs.343-394 crore

For Q1 FY27, the Uniresearch trailing-growth estimate for revenue is Rs.343-394 crore. The comparison base given is Q1 FY26 revenue of Rs.452 crore. The table in the provided material shows year-on-year growth of -18.5% against that Q1 FY26 base. The range framing implies uncertainty around demand, pricing, or volumes, but the provided text does not attribute a specific operational driver. What is clear is that the estimate is below the prior-year quarter’s reported revenue. Readers should note that the preview treats this as an estimate range ahead of the actual announcement. The company’s results are expected in the July-August 2026 window for the quarter ended June 2026.

PAT estimate range: Rs.-79 to -101 crore

The preview’s PAT estimate for Q1 FY27 is Rs.-79 to -101 crore. The comparable figure provided for Q1 FY26 net profit is Rs.-60 crore. In the same table, the YoY growth for PAT is shown as +50.0%, even though the range and sign convention in the text indicates a loss. The article also references Q4 FY26 net profit of Rs.-28 crore as the latest reported quarterly outcome ahead of Q1 FY27. Taken together, the preview is positioned around continued losses, with the Q1 FY27 estimate presented as a range. The P/E being described as “not meaningful” aligns with the loss-making context described in the same preview. Beyond these figures, the supplied text does not provide segmental or margin-level drivers for the PAT range.

Results timing and compliance signals

The Q1 FY27 results date is described as “July-August 2026 (indicative)”. The preview reiterates that this aligns with the broader NSE and BSE results season for the quarter ending June 2026. In a separate company update included in the material, Thirumalai Chemicals said its trading window for dealing in equity shares would be closed from 1 July 2026. The window will remain shut until 48 hours after the announcement of unaudited financial results for the quarter ended 30 June 2026. The disclosure cites SEBI’s Prohibition of Insider Trading Regulations, 2015. The update describes this as a routine compliance measure while quarterly results are being finalised. Practically, it restricts directors, employees, and other designated persons from trading during the closure period.

Stock levels and the 12-month target range

The context places the stock at a CMP of Rs.175. It also provides a 12-month target range of Rs.140-163, labelled as a Uniresearch estimate. The article characterises the target range as reflecting “tracking with a cautious bias stance.” This target range is presented alongside the Q1 FY27 estimate table and is not tied to a stated valuation method in the supplied text. Because the target band sits below the cited CMP, it frames the preview as conservative heading into the print. The material also includes an intraday reference showing Rs.167.00 at 15:57 on 30-06-2026 with a change of 7.10 (4.44%), but the preview’s main CMP reference remains Rs.175.

Key numbers at a glance

Market impact: what the setup implies for investors

The immediate market setup in the provided text is shaped by three datapoints: a CMP of Rs.175, losses in recent quarters, and a sub-CMP 12-month target range of Rs.140-163. The “not meaningful” P/E label signals that earnings-based valuation is less informative when net profit is negative. The revenue estimate range of Rs.343-394 crore versus Rs.452 crore in Q1 FY26 indicates that the preview expects a weaker top line on a year-on-year basis. The PAT range of Rs.-79 to -101 crore, compared with Rs.-60 crore in Q1 FY26, keeps the focus on the extent and trajectory of losses. The trading window closure is not a performance indicator, but it is a standard pre-results governance signal and can heighten attention on the upcoming announcement. Because the provided material does not include management commentary, any deeper operational interpretation would go beyond what is stated.

Analysis and conclusion

The preview is primarily a numbers-led setup for the Q1 FY27 print, anchored to Q1 FY26 and the most recent Q4 FY26 results. It highlights that revenue is expected to be below the prior-year quarter and that losses are still expected, based on the cited estimate ranges. It also frames expectations with a 12-month target range that is lower than the cited CMP, reinforcing a cautious positioning in the text. Separately, the trading window closure from 1 July 2026 until 48 hours after the results is a routine compliance disclosure under SEBI’s insider trading rules, and it points to an approaching unaudited results announcement. The next concrete milestone in the supplied information is the company’s Q1 FY27 results release in the July-August 2026 window.